Pulmonary affectation of vasculitis
Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to...
Gespeichert in:
Veröffentlicht in: | Archivos de bronconeumología (English ed.) 2012-11, Vol.48 (11), p.410-418 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 418 |
---|---|
container_issue | 11 |
container_start_page | 410 |
container_title | Archivos de bronconeumología (English ed.) |
container_volume | 48 |
creator | Martín-Suñé, Natalia Ríos-Blanco, Juan José |
description | Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis. |
doi_str_mv | 10.1016/j.arbres.2012.04.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1237093220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1237093220</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-e2ef61303ab497343340f9ca25dff9b91d27b15aa69f4d4bf1a89715b1a74a783</originalsourceid><addsrcrecordid>eNo1j01LxDAUAIMg7rr6D0QKXry0vveSJs1RFleFBT3ouby0CXTpl00r-O9dcD3NZRgYIW4QMgTUD4eMJzf5mBEgZaAyAHMm1pgbmxKSXYnLGA8AWiPihVgR6YI0qLW4e1_abuh5-kk4BF_NPDdDnwwh-eZYLW0zN_FKnAduo78-cSM-d08f25d0__b8un3cpyMqnFNPPmiUINkpa6SSUkGwFVNeh2CdxZqMw5xZ26Bq5QJyYQ3mDtkoNoXciPu_7jgNX4uPc9k1sfJty70fllgiSQNWEsFRvT2pi-t8XY5T0x0fyv8x-QtfW053</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237093220</pqid></control><display><type>article</type><title>Pulmonary affectation of vasculitis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</creator><creatorcontrib>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</creatorcontrib><description>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</description><identifier>EISSN: 1579-2129</identifier><identifier>DOI: 10.1016/j.arbres.2012.04.007</identifier><identifier>PMID: 22682604</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Combined Modality Therapy ; Granuloma, Respiratory Tract - etiology ; Granuloma, Respiratory Tract - pathology ; Granulomatosis with Polyangiitis - complications ; Granulomatosis with Polyangiitis - pathology ; Granulomatosis with Polyangiitis - therapy ; Hemorrhage - etiology ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunosuppressive Agents - therapeutic use ; Lung - blood supply ; Lung Diseases - etiology ; Lung Diseases - pathology ; Methotrexate - therapeutic use ; Plasmapheresis ; Rituximab ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Vasculitis - classification ; Vasculitis - complications ; Vasculitis - drug therapy ; Vasculitis - pathology ; Vasculitis - therapy</subject><ispartof>Archivos de bronconeumología (English ed.), 2012-11, Vol.48 (11), p.410-418</ispartof><rights>Copyright © 2012 SEPAR. Published by Elsevier España, S.L. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22682604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martín-Suñé, Natalia</creatorcontrib><creatorcontrib>Ríos-Blanco, Juan José</creatorcontrib><title>Pulmonary affectation of vasculitis</title><title>Archivos de bronconeumología (English ed.)</title><addtitle>Arch Bronconeumol</addtitle><description>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Granuloma, Respiratory Tract - etiology</subject><subject>Granuloma, Respiratory Tract - pathology</subject><subject>Granulomatosis with Polyangiitis - complications</subject><subject>Granulomatosis with Polyangiitis - pathology</subject><subject>Granulomatosis with Polyangiitis - therapy</subject><subject>Hemorrhage - etiology</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Lung - blood supply</subject><subject>Lung Diseases - etiology</subject><subject>Lung Diseases - pathology</subject><subject>Methotrexate - therapeutic use</subject><subject>Plasmapheresis</subject><subject>Rituximab</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>Vasculitis - classification</subject><subject>Vasculitis - complications</subject><subject>Vasculitis - drug therapy</subject><subject>Vasculitis - pathology</subject><subject>Vasculitis - therapy</subject><issn>1579-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j01LxDAUAIMg7rr6D0QKXry0vveSJs1RFleFBT3ouby0CXTpl00r-O9dcD3NZRgYIW4QMgTUD4eMJzf5mBEgZaAyAHMm1pgbmxKSXYnLGA8AWiPihVgR6YI0qLW4e1_abuh5-kk4BF_NPDdDnwwh-eZYLW0zN_FKnAduo78-cSM-d08f25d0__b8un3cpyMqnFNPPmiUINkpa6SSUkGwFVNeh2CdxZqMw5xZ26Bq5QJyYQ3mDtkoNoXciPu_7jgNX4uPc9k1sfJty70fllgiSQNWEsFRvT2pi-t8XY5T0x0fyv8x-QtfW053</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Martín-Suñé, Natalia</creator><creator>Ríos-Blanco, Juan José</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>Pulmonary affectation of vasculitis</title><author>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-e2ef61303ab497343340f9ca25dff9b91d27b15aa69f4d4bf1a89715b1a74a783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2012</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Granuloma, Respiratory Tract - etiology</topic><topic>Granuloma, Respiratory Tract - pathology</topic><topic>Granulomatosis with Polyangiitis - complications</topic><topic>Granulomatosis with Polyangiitis - pathology</topic><topic>Granulomatosis with Polyangiitis - therapy</topic><topic>Hemorrhage - etiology</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Lung - blood supply</topic><topic>Lung Diseases - etiology</topic><topic>Lung Diseases - pathology</topic><topic>Methotrexate - therapeutic use</topic><topic>Plasmapheresis</topic><topic>Rituximab</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>Vasculitis - classification</topic><topic>Vasculitis - complications</topic><topic>Vasculitis - drug therapy</topic><topic>Vasculitis - pathology</topic><topic>Vasculitis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martín-Suñé, Natalia</creatorcontrib><creatorcontrib>Ríos-Blanco, Juan José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archivos de bronconeumología (English ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martín-Suñé, Natalia</au><au>Ríos-Blanco, Juan José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary affectation of vasculitis</atitle><jtitle>Archivos de bronconeumología (English ed.)</jtitle><addtitle>Arch Bronconeumol</addtitle><date>2012-11</date><risdate>2012</risdate><volume>48</volume><issue>11</issue><spage>410</spage><epage>418</epage><pages>410-418</pages><eissn>1579-2129</eissn><abstract>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</abstract><cop>Spain</cop><pmid>22682604</pmid><doi>10.1016/j.arbres.2012.04.007</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1579-2129 |
ispartof | Archivos de bronconeumología (English ed.), 2012-11, Vol.48 (11), p.410-418 |
issn | 1579-2129 |
language | eng ; spa |
recordid | cdi_proquest_miscellaneous_1237093220 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adrenal Cortex Hormones - therapeutic use Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy Antibodies, Monoclonal, Murine-Derived - therapeutic use Combined Modality Therapy Granuloma, Respiratory Tract - etiology Granuloma, Respiratory Tract - pathology Granulomatosis with Polyangiitis - complications Granulomatosis with Polyangiitis - pathology Granulomatosis with Polyangiitis - therapy Hemorrhage - etiology Humans Immunoglobulins, Intravenous - therapeutic use Immunosuppressive Agents - therapeutic use Lung - blood supply Lung Diseases - etiology Lung Diseases - pathology Methotrexate - therapeutic use Plasmapheresis Rituximab Tumor Necrosis Factor-alpha - antagonists & inhibitors Vasculitis - classification Vasculitis - complications Vasculitis - drug therapy Vasculitis - pathology Vasculitis - therapy |
title | Pulmonary affectation of vasculitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20affectation%20of%20vasculitis&rft.jtitle=Archivos%20de%20bronconeumologi%CC%81a%20(English%20ed.)&rft.au=Mart%C3%ADn-Su%C3%B1%C3%A9,%20Natalia&rft.date=2012-11&rft.volume=48&rft.issue=11&rft.spage=410&rft.epage=418&rft.pages=410-418&rft.eissn=1579-2129&rft_id=info:doi/10.1016/j.arbres.2012.04.007&rft_dat=%3Cproquest_pubme%3E1237093220%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237093220&rft_id=info:pmid/22682604&rfr_iscdi=true |